Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the company's vaccine platform. The non-dilutive financing builds upon the award-winning €30 million seed financing raised in 2022 and demonstrates great confidence in the company's potential.Leuven, Belgium, May 30, 2023– AstriVax is pleased to announce that it has been selected for funding by Flanders Innovation & Entrepreneurship (VLAIO). The company has...
Nasdaq GlobeNewswire
30/05/2023
Lancets Market worth $3.6 billion | MarketsandMarkets
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487 Browse in-depth TOC on "Lancets Market" 206 - Tables 44 - Figures 219 - Pages Lancets Market Scope: Safety Lancets segment is expected to account for the largest share in 2022. The lancets market, by type has been segmented into safety and standard lancets...
PR Newswire
29/05/2023
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence…
Key Takeaways Key Takeaways Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/278 Key Trends and Dynamics of Pain Relief Therapeutics Market Growing prevalence of chronic pain disorders, rising incidence of traumatic injuries, and surge in the elderly populace are primarily aiding the expansion of this marketplace. Furthermore, increased pervasiveness of lifestyle-based ailments, sure in healthcare expenditure, along with rising R&D investments...
PR Newswire
29/05/2023
Diabetic Retinopathy Clinical Trial Pipeline Space Brims With Novel Emerging…
Key Takeaways from the Diabetic Retinopathy Pipeline Report Key Takeaways from the Diabetic Retinopathy Pipeline Report Request a sample and discover the recent advances in diabetic retinopathy drug treatment @Diabetic Retinopathy Pipeline Report The diabetic retinopathy pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage diabetic retinopathy drugs, inactive and dormant assets, a comprehensive assessment of...
PR Newswire
29/05/2023
Intraocular Lens (IOL) Market to Grow Phenomenally by 2029- Brandessence Market…
Key Takeaways Key Takeaways The Intraocular Lens (IOL) Market is anticipated to garner significant returns over the assessment timeline of 2022-2029. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/282 Elaborating the Key Trends and Dynamics of Intraocular Lens (IOL) Market Growing prevalence of ocular disorders, increased screen time of individuals, and widespread technological advancements in the field are primarily augmenting the outlook of...
PR Newswire
29/05/2023
Coronary Stents Market to Witness Phenomenal Gains by 2029- Brandessence Market…
Key Takeaways Key Takeaways Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/275 Elaborating The Key Trends and Dynamics of Coronary Stents Market Growing prevalence of cardiac ailments, surge in the geriatric population base, and escalating demand for minimally invasive treatment procedures are primarily aiding the market expansion. Also, rise in the geriatric population base, excessive smoking and alcohol intake, and technological innovations in...
PR Newswire
29/05/2023
Arthroscopy Market to Showcase Remarkable Growth by 2029- Brandessence Market…
Key Takeaways Key Takeaways The Arthroscopy Market is expected to witness phenomenal gains over the analysis timeline of 2022-2029. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/281 Elaborating The Key Trends and Dynamics of Arthroscopy Market Growing prevalence of joint-related disorders along with the rising instances of injuries triggered by accidents, falls, and sports activities are primarily augmenting the industry outlook. Alongside,...
PR Newswire
29/05/2023
VAPORESSO Showcases Innovative Vaping Products at VAPITALY 2023, Highlighting…
The company has also showcased its highly popular XROS Series and LUXE X Series, along with other products such as the TARGET and GEN series, demonstrating its dedication to producing cutting-edge vaping technology that meets the evolving needs of its customers. Featuring VAPORESSO's COREX Heating Tech, SSS Leak Resistant Tech, and equipped VAPORESSO AXON CHIP, both the LUXE XR MAX and XROS 3 NANO have attracted significant attention during the exhibition. The company has also showcased its...
PR Newswire
29/05/2023
Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated…
Lower extremity Peripheral Arterial Disease (PAD) affects an estimated quarter million adults in Europe and North America and is associated with significant morbidity and mortality, with atherosclerosis being the main cause. Stenosed and occluded SFA remain major contributors to the PAD. Lower extremity Peripheral Arterial Disease (PAD) affects an estimated quarter million adults inEuropeandNorth Americaand is associated with significant morbidity and mortality, with atherosclerosis...
PR Newswire
29/05/2023
Urinalysis Market Anticipated to Garner $5,719.3 Million, Growing at a 6.4% CAGR…
As per the report published by Research Dive, the global urinalysis market is expected to register a revenue of $5.719.3 million by 2031 at a CAGR of 6.4% during the forecast period 2022-2031. As per the report published by Research Dive, theglobal urinalysis market is expected to register a revenue of$5.719.3 millionby 2031 at a CAGR of 6.4% during the forecast period 2022-2031. Segments of the Urinalysis Market The report has divided the urinalysis market into the following...
PR Newswire
29/05/2023
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 -…
Key Takeaways Key Takeaways Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/277 Elaborating the Key Trends and Dynamics of Lung Cancer Therapies Market Rise in the number of smokers, increasing air pollution levels, and growing healthcare spending across numerous regions are primarily augmenting the outlook of this business sphere. Also, exposure to harmful radiation or toxins in workplaces, rapid industrialization, and high frequency of product...
PR Newswire
29/05/2023
ABIOGEN PHARMA COMPLETES THE ACQUISITION OF EFFRX
"Besides strengthening our position in Italy – explained Massimo Di Martino, Chairman and CEO of Abiogen Pharma – the acquisition of a majority interest in EffRx is in line with our growth model, serves as a launching pad for our international expansion and confirms our mission and commitment to bone health and rare diseases". "Besides strengthening our position inItaly– explained Massimo Di Martino ,Chairman and CEO of Abiogen Pharma– the acquisition of a majority interest in…
PR Newswire
29/05/2023
ABIOGEN PHARMA COMPLETES THE ACQUISITION OF EFFRX
"Besides strengthening our position in Italy – explained Massimo Di Martino, Chairman and CEO of Abiogen Pharma – the acquisition of a majority interest in EffRx is in line with our growth model, serves as a launching pad for our international expansion and confirms our mission and commitment to bone health and rare diseases". "Besides strengthening our position inItaly– explained Massimo Di Martino ,Chairman and CEO of Abiogen Pharma– the acquisition of a majority interest in…
PR Newswire
29/05/2023
MAXIMA GRUPĖ concluded financing agreements for the total amount of 100 m. EUR
According to Agnė Voverė, CEO of MAXIMA GRUPĖ, the main direction of the company continues to be the development of retail chains managed by the group in Poland and Bulgaria. The group's plans include the redemption of bonds issued five years ago and investments in retail solutions. The recently concluded financing agreements will contribute to the implementation of future plans, including investments in operational efficiency, development, and sustainability projects.Financing is provided...
Nasdaq GlobeNewswire
29/05/2023
Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as…
Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit CommitteeLiege, Belgium, 29 May 2023 – 7:30 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces the appointment of leading life sciences executive Dr.Christian Homsy as Chairman of the Board of Directors.The Board of Directors also appointed Inge Beernaert as President of the Compensation and Nomination Committee...
Nasdaq GlobeNewswire
29/05/2023
Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data…
Tregs play a central role in managing immune self-tolerance and depleted or dysfunctional Tregs are characteristic of many autoimmune disorders. "There has been interest in using Tregs as a treatment for autoimmune disorders for many years. However, to date, these efforts have been limited by lack of antigen-specificity and persistence. The ability to create stable/functional Treg cells that are antigen-specific has until now been elusive. We believe that RegCell's proprietary platform can…
PR Newswire
29/05/2023
BioSenic provides update regarding current license agreement with Phebra
INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also currently negotiating a potential renegotiation of the other licensing termsMont-Saint-Guibert, Belgium , May29 th 2023 , 7 .00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell...
Nasdaq GlobeNewswire
29/05/2023
Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive…
Dr. Murphy's team has successfully demonstrated the protection of mitochondrial DNA from radiation in these subjects, marking a significant milestone in medical literature. The group given the antioxidant formulation exhibited a 54% decrease in mitochondrial DNA damage based on STAT 3 testing when compared to the placebo group. Considering that mitochondrial DNA is inherited maternally and is 13 times more vulnerable to radiation than nuclear DNA, this achievement holds tremendous promise. Dr...
PR Newswire
27/05/2023
Results of the votes of the Combined Shareholders' General Meeting of May 25…
Daix (France), Long Island City (New York, United States), May 26, 2023– Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with unmet medical need, today announced the results of the votes of its Combined Shareholders' Meeting. The Combined Shareholders' Meeting was held on Thursday May 25, 2023 at 2 p.m...
Nasdaq GlobeNewswire
26/05/2023
Information on the Total Number of Voting Rights (Denominator) following…
Regulated Information - Denominator Atlas Special Opportunities, LLChas converted 4convertible bonds in Oxurion resulting in a EUR 100 ,000capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion.Leuven, BELGIUM ,Boston, MA, US–May ...
Nasdaq GlobeNewswire
26/05/2023
Human Microbiome Market worth $1.7 billion | MarketsandMarkets
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904 Browse in-depth TOC on "Human Microbiome Market" 161 - Tables 34 - Figures 189 - Pages Human Microbiome Market Scope: Therapeutic segment accounted for the largest share of the human microbiome market Among the application, the human microbiome market is segmented...
PR Newswire
26/05/2023
Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the…
The webinar will feature key opinion leaders (KOLs) Richard Vile, Ph.D., (Mayo Clinic), Aleix Prat, M.D., Ph.D. (Clínic Barcelona), and Martine J. Piccart, M.D., Ph.D. (Université Libre de Bruxelles), who will join the Oncolytics management team for a discussion on the current treatment landscape for HR+/HER2- metastatic breast cancer, as well as BRACELET-1's results. The webinar will feature key opinion leaders (KOLs)Richard Vile, Ph.D., (Mayo Clinic),Aleix Prat, M.D., Ph.D. (Clínic...
PR Newswire
26/05/2023
Guerbet: Changes in Guerbet's Board of Directors
Changes in Guerbet's Board of Directors Appointment of Didier Izabel as Chair of the Board of DirectorsAppointment of Pascale Auger as an Independent DirectorRenewal of three directorships Villepinte, 26 May 2023: Guerbet(FR0000032526 GBT), aworld specialist in contrast products and solutions for medical imaging, announces, following the Annual General Meeting of 26 May 2023 and a Board of Directors meeting held on the same day: the appointment of Didier Izabel as...
Nasdaq GlobeNewswire
26/05/2023
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral…
Just months after seeing their flagship asset pelareorep gain FDA Fast Track Designation for the treatment of advanced/metastatic pancreatic cancer, Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) is set to deliver more optimism at this year's ASCO in an oral presentation on June 3, 2023. Just months after seeing their flagship asset pelareorep gainFDA Fast Track Designation for the treatment of advanced/metastatic pancreatic cancer,Oncolytics Biotech Inc.(NASDAQ:ONCY) (TSX:ONC) is set...
PR Newswire
26/05/2023
Altri Comunicati
